alpha-aminopyridine has been researched along with Mucositis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohemier, C; Cabanero, M; Chen, E; Goodwin, R; Jonker, D; Kennecke, H; Lim, H; Ritter, H; Seymour, L; Tsao, MS; Tu, D; Vickers, M | 1 |
1 trial(s) available for alpha-aminopyridine and Mucositis
| Article | Year |
|---|---|
A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer.
Topics: Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Exanthema; Fatigue; Female; Humans; Male; Middle Aged; Morpholines; Mucositis; Panitumumab; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase | 2020 |